Keyphrases
Active Molecules
16%
Activity in Vivo
16%
Antibacterial Target
16%
Antimicrobial
16%
Antimicrobial Therapy
16%
Antitubercular Agents
16%
Approved Drug Library
16%
Bacterial Resistance
16%
Carbon Source
16%
Cholesterol
100%
Current Treatment
33%
Dapsone
100%
Dihydropteroate Synthase
16%
Drug Screening
16%
Hypoxia
16%
In Vitro Resistance
16%
In Vivo Activity
16%
In Vivo Analysis
16%
Latent Infection
50%
Latently Infected
16%
M. Bovis BCG
16%
Mycobacterium
100%
Mycobacterium Bovis BCG
16%
Mycobacterium Tuberculosis (M. tb)
16%
Non-replicating
100%
Non-replicating Persistence
100%
Overexpression
16%
Phenotypic Screen
16%
Physiologically Relevant
16%
Resuscitation
16%
Target Enzyme
16%
Treatment Regime
16%
World Population
16%
Medicine and Dentistry
Antibiotic Resistance
25%
Antiinfective Agent
25%
Antimicrobial Therapy
25%
Carbon Source
25%
Dapsone
100%
Dihydropteroate Synthase
25%
Drug Screening
25%
Hypoxia
25%
In Vitro
50%
Infection
75%
Mycobacteria
100%
Mycobacterium Bovis BCG
50%
Mycobacterium Tuberculosis
25%
Resuscitation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
50%
Antimicrobial Resistance
25%
Dapsone
100%
Dihydropteroate Synthase
25%
Drug Screening
25%
Hypoxia
25%
Infection
75%
Mycobacteria
100%
Mycobacterium Bovis BCG
50%
Mycobacterium Tuberculosis
25%
Immunology and Microbiology
Antimicrobial Resistance
50%
Drug Screening
50%
Mycobacteria
100%
Mycobacterium Bovis BCG
100%
Mycobacterium Tuberculosis
50%